Curriculum Vitaes

kaneko chiyuki

  (金子 千之)

Profile Information

Affiliation
School of Health Sciences Faculty of Medical Technology, Fujita Health University
Degree
博士(医学)

J-GLOBAL ID
200901009977885332
researchmap Member ID
1000102773

Misc.

 103
  • KANEKO Chiyuki, KATO Yoshimitsu, YANAGIDA Takamasa, ABE Masato, KOSUGE Yuuko, IWAI Muneo
    Int J Anal Bio-Sci, 3(2) 37-40, Jun 30, 2015  
  • KANEKO Chiyuki, KATO Yoshimitsu, YANAGIDA Takamasa, ABE Masato, KOSUGE Yuuko, IWAI Muneo
    形態・機能, 12(2) 75-78, Mar 25, 2014  
    Helicobacter pylori (H. pylori) is a very important pathogenic bacteria associated with many upper gastrointestinal diseases including chronic active gastritis, chronic inactive gastritis, gastric and duodenal peptic ulcer disease, gastric MALT lymphoma, and gastric adenocarcinoma. There are no distinct endoscopic patterns of chronic H. pylori gastritis. The diagnosis of H. pylori gastritis is made by pathologic examination of gastric mucosal biopsies or by the detection of urease in mucosal specimens using the CLO test or urea breath test.  H. pylori infection has been diagnosed based on the histological laboratory procedure and indirectly from a background gastric-mucous-membrane view. Alcian Yellow Touidine Blue staining is available and useful as one of the diagnostic methods.
  • KANEKO Chiyuki, KOSUGE Yuuko, IWAI Muneo
    生物試料分析, 35(4) 342-346, Sep 30, 2012  
  • Kiyoshi Hasegawa, Kyoko Kawamura, Rina Kato, Shinichi Komiyama, Chiyuki Kaneko, Yasuhiro Udagawa
    ACTA CYTOLOGICA, 56(4) 394-400, 2012  
    Objective: We previously reported that oral administration of the selective cyclooxygenase-2 (COX-2) inhibitor etodolac results in antitumor effects in endometrial cancer tissue. Herein, we investigated whether these antitumor effects could be assessed using endometrial cytological findings. Study Design: Etodolac (400 mg b.i.d. for 2 weeks) was administered preoperatively to 21 endometrial cancer patients: 16 had COX-2-positive disease and 5 had COX-2-negative disease. Twenty-one pairs of pre- and post-etodolac-treatment endometrial cytological samples were collected to review changes in the cytological features. Results: In the COX-2-positive patients, nuclear atypia was slightly decreased in 3 of the 16 cases, while the mitotic index was decreased in all cases. Cellular overlapping and tumor cell cluster outlines were somewhat affected in 6 and 8 cases, respectively. Nuclear/cytoplasmic ratio, anisokaryosis and hyperchromasia were also reduced in 6, 4, and 2 cases, respectively; however, tumor diathesis and nucleoli features were unchanged. In contrast, endometrial cytological features did not appear to be affected in the 5 COX-2-negative patients. Conclusions: We conclude that the antitumor effects observed in endometrial cancer tissues following oral administration of etodolac are reflected in and can be easily assessed by evaluating endometrial cytological features. Copyright (c) 2012 S. Karger AG, Basel
  • Kiyoshi Hasegawa, Kyoko Kawamura, Rina Kato, Shinichi Komiyama, Chiyuki Kaneko, Yasuhiro Udagawa
    ACTA CYTOLOGICA, 56(4) 394-400, 2012  Peer-reviewed
    Objective: We previously reported that oral administration of the selective cyclooxygenase-2 (COX-2) inhibitor etodolac results in antitumor effects in endometrial cancer tissue. Herein, we investigated whether these antitumor effects could be assessed using endometrial cytological findings. Study Design: Etodolac (400 mg b.i.d. for 2 weeks) was administered preoperatively to 21 endometrial cancer patients: 16 had COX-2-positive disease and 5 had COX-2-negative disease. Twenty-one pairs of pre- and post-etodolac-treatment endometrial cytological samples were collected to review changes in the cytological features. Results: In the COX-2-positive patients, nuclear atypia was slightly decreased in 3 of the 16 cases, while the mitotic index was decreased in all cases. Cellular overlapping and tumor cell cluster outlines were somewhat affected in 6 and 8 cases, respectively. Nuclear/cytoplasmic ratio, anisokaryosis and hyperchromasia were also reduced in 6, 4, and 2 cases, respectively; however, tumor diathesis and nucleoli features were unchanged. In contrast, endometrial cytological features did not appear to be affected in the 5 COX-2-negative patients. Conclusions: We conclude that the antitumor effects observed in endometrial cancer tissues following oral administration of etodolac are reflected in and can be easily assessed by evaluating endometrial cytological features. Copyright (c) 2012 S. Karger AG, Basel

Books and Other Publications

 11

Presentations

 29

Teaching Experience

 3

教育内容・方法の工夫(授業評価等を含む)

 1
  • 件名(英語)
    -
    概要(英語)
    学生が興味を持てる様に写真や図表を入れる。

作成した教科書、教材、参考書

 2
  • 件名(英語)
    臨床細胞病理学実習書
    開始年月日(英語)
    2000
    概要(英語)
    臨床細胞病理学実習書
  • 件名(英語)
    国家試験用写真問題集、国家試験用問題集
    開始年月日(英語)
    2006
    概要(英語)
    国家試験対策問題集

その他教育活動上特記すべき事項

 1
  • 件名(英語)
    -
    概要(英語)
    医学部、医療科学部1年生のアセンブリ班に対して発表演奏会を行なった。